BioStone Animal Health Acquires American Animal Health Assets, Expands USDA-Licensed Autogenous Bacterin Manufacturing Capabilities

Southlake, TX / Grand Prairie, TX — February 23, 2026  — BioStone Animal Health announced today that it has acquired the business assets of American Animal Health, Inc. (AAH), including AAH’s USDA-licensed manufacturing facility in Grand Prairie, Texas (Est. 315). The acquisition strengthens BioStone’s ability to serve veterinarians and producers with high-quality, herd-specific autogenous bacterins supported by established manufacturing…

BioStone Animal Health was Awarded the USDA SBIR Grant for Development of Avian Influenza Subtype H5 and H7 ELISAs

DALLAS-FORT WORTH, TX — September 28, 2023 — BioStone Animal Health is pleased to announce that the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) has awarded a Phase I SBIR grant to investigate and develop diagnostics for Avian Influenza. The awarded project is entitled “An Enzyme-Linked Immunosorbent Assay To Detect…